Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Annals of Neurology

• Publication date

  1991-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.410300308PMID 1683212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons

  2004cited by this paper
• Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

  1991cited by this paper
• Cholinergic deficiency and frontal dysfunction in Parkinson's disease

  1990cited by this paper
• Tyrosine hydroxylase-like (TH) immunoreactivity in human mesolimbic system.

  1990cited by this paper
• Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

  1990cited by this paper
• Motor set in Parkinson's disease.

  1990cited by this paper
• MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate.

  1990cited by this paper
• Neurotensin innervation of the human cerebral cortex: lack of colocalization with catecholamines.

  1990cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.

  1990cited by this paper
• Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine‐beta‐hydroxylase

  1989cited by this paper
• Noradrenergic innervation of monkey prefrontal cortex: A dopamine‐β‐hydroxylase immunohistochemical study

  1989cited by this paper
• Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex.

  1989cited by this paper
• Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

  1989cited by this paper
• Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex.

  1989cited by this paper
• Motor planning is impaired in Parkinson's disease.

  1988cited by this paper
• Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: A radioautographic study

  1988cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper
• Distribution of choline acetyltransferase‐, serotonin‐, dopamine‐β‐hydroxylase‐, tyrosine hydroxylase‐immunoreactive fibers in monkey primary auditory cortex

  1987cited by this paper
• A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics

  1987cited by this paper
• The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific

  1987cited by this paper
• Readiness potential of cortical area 6 preceding self paced movement in Parkinson's disease.

  1987cited by this paper
• Cognitive concomitants of dopamine system stimulation in parkinsonian patients.

  1987cited by this paper
• Parkinson's disease

  1987cited by this paper
• Parkinson's disease and dementia

  1987cited by this paper
• Catecholamine sensitivities of neurons related to a visual reaction time task in the monkey prefrontal cortex.

  1987cited by this paper
• Major dopamine innervation of the cortical motor areas in the cynomolgus monkey. A radioautographic study with comparative assessment of serotonergic afferents.

  1986cited by this paper
• Efferent projections of nucleus locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction.

  1986cited by this paper
• Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.

  1986cited by this paper
• Pathologic correlates of dementia in Parkinson's disease.

  1986cited by this paper
• Intellectual changes in patients with MPTP‐induced parkinsonism

  1985cited by this paper
• Catecholaminergic innervation of the septal area in man: Immunocytochemical study using TH and DBH antibodies

  1985cited by this paper
• Biochemical neuropathology of Parkinson's disease.

  1984cited by this paper
• Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex

  1984cited by this paper
• Basic Mechanisms of Neuronal Hyperexcitability, Vol. 2, H.H. Jasper, N.M. van Gelder (Eds.), in: Neurology and Neurobiology. Alan R. Liss, Inc. (1983), xvi+ 495, £73, ISBN: 0 8451 2701 2

  1984cited by this paper
• Dementia in idiopathic Parkinson's disease

  1984cited by this paper
• Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

  1984cited by this paper
• A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.

  1983cited by this paper
• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  1983cited by this paper
• Cognitive deficits in the early stages of Parkinson's disease.

  1983cited by this paper
• PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE

  1983cited by this paper
• Cognitive fluctuations associated with on‐off phenomenon in Parkinson disease

  1982cited by this paper
• Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry.

  1982cited by this paper
• Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP

  1982cited by this paper
• Reaction time in Parkinson's disease.

  1981cited by this paper
• Brain neurotransmitter changes in Parkinson's disease

  1981cited by this paper
• Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat.

  1980cited by this paper
• Stereological Methods. Practical methods for biological morphometry

  1979cited by this paper
• Practical methods for biological morphometry

  1979cited by this paper
• Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex.

  1979cited by this paper
• Organization of catecholamine neurons projecting to the frontal cortex in the rat.

  1978cited by this paper
• Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

  1978cited by this paper
• Clinical consequences of corticectomies involving the supplementary motor area in man.

  1977cited by this paper
• The projection of the locus coeruleus upon the neocortex in the macaque monkey.

  1977cited by this paper
• Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study.

  1976cited by this paper
• Different forms of tyrosine hydroxylase in central dopaminergic and noradrenergic neurons and sympathetic ganglia.

  1975cited by this paper
• An electron microscope study of the termination of afferent connections to the primate motor cortex

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• THE BRAIN-STEM LESIONS IN PARKINSONISM

  1953cited by this paper

• Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Monkey Model of Parkinson's Disease.

  2026cites this paper
• Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism

  2026cites this paper
• Rotarod training reverses corticosterone-induced motor deficits via oligodendrocyte lineage cell modulation.

  2025cites this paper
• A possible pathway to freezing of gait in Parkinson's disease

  2025cites this paper
• A Computational Neural Network Model Depicting Bradykinesia in Parkinson’s Disease

  2025cites this paper
• Dysfunction of motor cortices in Parkinson’s disease

  2024cites this paper
• Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer’s disease and Parkinson’s disease

  2024cites this paper
• Reduced Thalamic Excitation to Motor Cortical Pyramidal Tract Neurons in a Mouse Model of Parkinsonism

  2023cites this paper
• Structural and neurophysiological alterations in Parkinson’s disease are aligned with cortical neurochemical systems

  2023cites this paper
• Updates on brain regions and neuronal circuits of movement disorders in Parkinson's disease.

  2023cites this paper
• Age-Dependent Modulation of Layer V Pyramidal Neuron Excitability in the Mouse Primary Motor Cortex by D1 Receptor Agonists and Antagonists.

  2023cites this paper
• Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease.

  2023cites this paper
• Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study

  2023cites this paper
• Further insight into the role of primary motor cortex in bradykinesia pathophysiology.

  2023cites this paper
• Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.

  2023cites this paper
• Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems

  2023cites this paper
• Age-dependent modulation of the excitability of layer V pyramidal neurons by dopamine D1 receptors in mice’s primary motor cortex

  2023cites this paper
• Oscillatory waveform sharpness asymmetry changes in motor thalamus and motor cortex in a rat model of Parkinson’s disease

  2022influential citation
• Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's disease.

  2022cites this paper
• Reduced norepinephrine transporter binding in Parkinson's disease with dopa responsive freezing gait

  2022cites this paper
• Transcranial Direct Current Stimulation on Different Targets to Modulate Cortical Activity and Dual-Task Walking in Individuals With Parkinson’s Disease: A Double Blinded Randomized Controlled Trial

  2022cites this paper
• Endogenous dopamine transmission is crucial for motor skill recovery after stroke

  2022cites this paper
• N200 and P300 component changes in Parkinson’s disease: a meta-analysis

  2022cites this paper
• Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.

  2021cites this paper
• Reward-Related Responses and Tonic Craving in Cocaine Addiction: An Imaging Study of the Monetary Incentive Delay Task

  2021cites this paper
• The LC-NE system as a potential target for neuromodulation to ameliorate non-motor symptoms in Parkinson's disease.

  2021cites this paper
• Forelimb Motor Skills Deficits Following Thoracic Spinal Cord Injury: Underlying Dopaminergic and Neural Oscillatory Changes in Rat Primary Motor Cortex

  2021cites this paper
• Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.

  2021cites this paper
• Primary motor cortex in Parkinson's disease: Functional changes and opportunities for neurostimulation.

  2020cites this paper
• Clinical and Electrophysiological Hints to TMS in De Novo Patients with Parkinson’s Disease and Progressive Supranuclear Palsy

  2020cites this paper
• Distinct local and brain-wide networks are activated by layer-specific optogenetic stimulations of motor cortex

  2020cites this paper
• Reduced Dopamine Signaling Impacts Pyramidal Neuron Excitability in Mouse Motor Cortex

  2020cites this paper
• Profiles of women in science: Patricia Gaspar, Emeritus Researcher at Inserm in the Institut du Fer a Moulin

  2020cites this paper
• Understanding the neurophysiological and molecular mechanisms of exercise-induced neuroplasticity in cortical and descending motor pathways: Where do we stand?

  2020cites this paper
• Parkinson's disease: From bench to bedside.

  2020cites this paper
• Cell Biology International

  2019cites this paper
• The mRVG‐9R peptide as a potential therapeutic vector to the central nervous system cells

  2019cites this paper
• The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease.

  2019cites this paper
• Altered Recruitment of Motor Cortex Neuronal Activity During the Grasping Phase of Skilled Reaching in a Chronic Rat Model of Unilateral Parkinsonism

  2019cites this paper
• Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.

  2019cites this paper
• Compensatory dopaminergic‐cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease

  2019cites this paper
• Ventral tegmental area connections to motor and sensory cortical fields in humans

  2019cites this paper
• Neuromagnetic investigations of mechanisms and effects of STN-DBS and medication in Parkinson's disease

  2018cites this paper
• Longitudinal magnetic resonance imaging of cognitive impairment in Parkinson’s disease

  2018cites this paper
• Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients

  2018cites this paper
• The Effect of Embryonic Alcohol Exposure on Brain Function and Behavior in Zebrafish Strains

  2018cites this paper
• Disruption of Cortical Dopaminergic Modulation Impairs Preparatory Activity and Delays Licking Initiation

  2018cites this paper
• Basal Ganglia: Bradykinesia Models

  2018cites this paper
• Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease

  2018cites this paper
• Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models.

  2018cites this paper
• Imaging of Motor Cortex Physiology in Parkinson's Disease

  2018cites this paper
• Association of the rs1611115 polymorphism in DBH gene with Parkinson’s disease: a meta-analysis

  2018cites this paper
• Changes of motor corticobulbar projections following different lesion types affecting the central nervous system in adult macaque monkeys

  2018cites this paper
• Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states

  2018cites this paper
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

  2018cites this paper
• Striatal norepinephrine efflux in L‐DOPA‐induced dyskinesia

  2018cites this paper
• Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations

  2018cites this paper
• Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex

  2017influential citation
• Monoaminergic Modulation of Motor Cortex Function

  2017cites this paper
• Parkinson’s Disease and the Cerebral Cortex

  2017cites this paper
• Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation

  2017cites this paper
• Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse

  2017cites this paper
• Dopamine controls Parkinson’s tremor by inhibiting the cerebellar thalamus

  2017cites this paper
• Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex

  2017cites this paper
• Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson’s Disease

  2016cites this paper
• Risk of Parkinson's Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies

  2016cites this paper
• Temporal discrimination threshold with healthy aging.

  2016cites this paper
• The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats

  2016cites this paper
• Are the Symptoms of Parkinsonism Cortical in Origin?☆☆☆

  2016cites this paper
• Chapter 15 – Parkinsonism

  2016cites this paper
• Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice.

  2016cites this paper
• Tract Neuron Activity in the Rodent Motor Cortex Local Application of Dopamine Inhibits Pyramidal

  2015cites this paper
• Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.

  2015influential citation
• Chapitre 3 – Étiopathogénie

  2015cites this paper
• Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state

  2015cites this paper
• Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease

  2015influential citation
• Cerebellum in Levodopa-Induced Dyskinesias: The Unusual Suspect in the Motor Network

  2014cites this paper
• Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors

  2014cites this paper
• The Role of the Noradrenergic System and Its Receptors in Levodopa-Induced Dyskinesia

  2014cites this paper
• Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency.

  2014cites this paper
• Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

  2014cites this paper
• Amphetamine stimulates movement through thalamocortical glutamate release

  2014cites this paper
• The role of sensorimotor cortical plasticity in pathophysiology of Parkinson’s disease and dystonia

  2014cites this paper
• Age-related decline in the responsiveness of motor cortex to plastic forces reverses with levodopa or cerebellar stimulation.

  2014cites this paper
• Serotonergic pharmacology in animal models: from behavioral disorders to dyskinesia.

  2014cites this paper
• Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease

  2013cites this paper
• Mechanisms underlying cortical resonant states: implications for levodopa-induced dyskinesia

  2013cites this paper
• Bradykinesia models of Parkinson's disease

  2013cites this paper
• Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

  2013cites this paper
• Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease

  2013cites this paper
• Parkinson's disease and sex-related differences in electromyography during daily life.

  2013cites this paper
• Per Petersson Mechanisms underlying cortical resonant states : implications for levodopa-induced dyskinesia

  2013cites this paper
• Novel mechanisms underlying inhibitory and facilitatory transcranial magnetic stimulation abnormalities in Parkinson's disease.

  2013cites this paper
• Dopaminergic Meso-Cortical Projections to M1: Role in Motor Learning and Motor Cortex Plasticity

  2013cites this paper
• Daily physical function and frailty in persons with Parkinson's disease : a focus on females

  2013cites this paper
• Association between Striatal Subregions and Extrastriatal Regions in Dopamine D1 Receptor Expression: A Positron Emission Tomography Study

  2012cites this paper
• Développement d'un modèle animal chez le rat reproduisant un déficit motivationnel pouvant s'apparenter à un syndrome d'apathie de la maladie de Parkinson

  2012cites this paper
• Functional reorganization of sensorimotor cortex in early Parkinson disease

  2012cites this paper
• Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts

  2012cites this paper
• Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor.

  2012cites this paper